Clinical Trial

Dexmedetomidine for Intraoperative Shivering in Scheduled Elective Cesarean Delivery

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine the optimum dose of Dexmedetomidine to stop shivering in 90% of patients who experience shivering during scheduled elective cesarean deliveries.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2021-01-28; most recent amendment 2025-09-05.
Status change: Not Yet Recruiting → Recruiting 2021-09-21
Trial Details
NCT Number NCT04730609
Lead Sponsor Mayo Clinic
Conditions Shivering, Dose Finding Study
Enrollment 40 participants
Start Date 2021-09-21
Primary Completion 2026-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2025-09-11